District Cannabis has completed their pharmaceutical-grade manufacturing facility in Hagerstown, MD. The facility, which was made possible due to a successful capital raise of $9.2 M, will produce consistently high-quality cannabis to meet Maryland's growing patient demand.
"The Hagerstown facility's footprint will ultimately encompass more than 82,000 sq ft, including the recently completed Phase 1 high-tech grow rooms, and the Phase 2 expansion planned for later this year. The cultivation complex, upon completion of Phase 2, is expected to yield more than 6 times the current production capacity," the team with the company explains.
"Our approach, from the beginning, has been one rooted in science and is patient centric. With the arrival of our new Maryland facility, we are able to expand our reach in the patient community and ensure that Maryland patients have access to medicine that adheres to the lofty standards that the medical cannabis community has come to expect," stated Co-Founder and Chairman Ed Weidenfeld.
"We're thrilled to call Hagerstown our home in Maryland. The city and the local business community have welcomed us with open arms, and we are already planning to expand. We look forward to what I'm certain will be a positive long term relationship." said Co-Founder and CEO Andras Kirschner.
"The City of Hagerstown is pleased to welcome District Cannabis/Maryland Cultivation and Processing to Hagerstown," said Mayor Bruchey. The addition of this new company will not only create jobs, but as one that has a proven reputation in its industry, promises to be a good fit for our business community."
For more information:
District Cannabis
[email protected]
districtcannabis.us